查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1458725

2024 年全球照护现场(POC)血液凝固检验市场报告

Point-of-Care (POC) Coagulation Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

由于心血管疾病（CVD）盛行率的增加，照护现场（POC）血液凝固检验市场预计将成长。 CVD包括多种影响心臟和血管的疾病，例如冠状动脉疾病和脑血管疾病。 POC血液凝固检验在 CVD 治疗中发挥重要作用，它可以提供凝血状态的即时讯息，从而可以及时进行干预并降低出血併发症的风险，尤其是在心血管手术后。例如，2023 年 5 月，美国疾病管制与预防中心报告称，心臟病将在 2021美国夺走美国约 695,000 人的生命，占死亡人数的五分之一。 2021 年，心臟疾病最常见的死亡原因为 375,476 人。心血管疾病盛行率的增加是支持 POC血液凝固检验市场成长的关键因素。

照护现场(POC)血液凝固检验市场的主要企业正在专注于策略联盟以增强竞争力。这种联盟涉及两方或多方之间的正式协议，以实现特定的互利目标。例如，2021年10月，Trivitron Healthcare与Diagon Ltd.和Vanguard Diagnostics合作推出了凝血分析仪产品。这些分析仪提供准确、高效的血液凝固检验，此次合作旨在加强患者诊断和管理。它的设计与各种医疗环境相容，使血液凝固检验更容易进行。

2023年12月，瑞士製药公司罗氏以3.5亿美元收购Lumiradex。此次收购增强了罗氏的诊断产品组合，并透过涵盖整个病人历程的护理点解决方案实现了更加以患者为中心的医疗保健。总部位于英国的 Lumiradex 专门照护现场血液凝固检验。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球照护现场(POC)血液凝固检验市场，依技术、性能及预测细分，2018-2023、2023-2028、2033
  • 光学技术
  • 机械技术
  • 电化学技术
  • 全球照护现场(POC)血液凝固检验市场，按分销管道细分、绩效和预测，2018-2023、2023-2028、2033
  • 直接竞标
  • 零售
  • 全球照护现场(POC)血液凝固检验市场，依最终用户细分，实际与预测，2018-2023、2023-2028、2033
  • 医院
  • 诊所
  • 居家照护

第 7 章 区域/国家分析

  • 全球照护现场(POC)血液凝固检验市场，按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球照护现场(POC)血液凝固检验市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 照护现场（POC）血液凝固检验市场的竞争格局
  • 照护现场(POC)血液凝固检验市场公司概况
    • AT&T Corporation
    • Siemens Healthcare GmbH
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.

第31章 其他大型创新企业

  • Danaher Corporation
  • Medtronic Plc
  • Koninklijke Philips NV
  • Sysmex Corporation
  • IDEXX Laboratories Inc.
  • Quidel Corporation
  • Bio-Rad Laboratories Inc.
  • Teleflex Incorporated
  • Werfen SA
  • Nihon Kohden Corporation
  • Horiba Ltd.
  • Hycel
  • Nova Biomedical Corporation
  • Haemonetics Corporation
  • Maccura Biotechnology Co. Ltd.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r16707

Point-of-care (POC) coagulation testing is a diagnostic method that evaluates blood clotting function at or near the patient's location, rather than in a centralized lab. It provides rapid results, typically within minutes, enabling healthcare professionals to make timely treatment decisions and optimize anticoagulation therapy.

The main technologies used in POC coagulation testing are optical, mechanical, and electrochemical. Optical technology utilizes light for various applications, including data transfer, imaging, and sensing. These tests are distributed through channels such as direct tenders and retail to end-users such as hospitals, clinics, and home care settings.

The point-of-care (POC) coagulation testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care (POC) coagulation testing market statistics, including point-of-care (POC) coagulation testing industry global market size, regional shares, competitors with a point-of-care (POC) coagulation testing market share, detailed point-of-care (POC) coagulation testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care (POC) coagulation testing industry. This point-of-care (POC) coagulation testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care (POC) coagulation testing market size has grown strongly in recent years. It will grow from $1.12 billion in 2023 to $1.18 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to several factors, including the rise in patient demand, the growing trend of point-of-care testing, the high reliability of coagulation status on PT tests, automation, and integration with electronic health records (EHRs), as well as the rising incidence of cardiovascular diseases and blood disorders.

The point-of-care (POC) coagulation testing market size is expected to see steady growth in the next few years. It will grow to $1.42 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The forecasted growth is driven by expanding applications in healthcare, increasing demand in homecare settings, and the rising prevalence of chronic blood disorders. Patient demand for rapid and accurate testing, along with the increase in point-of-care testing, also contribute to this growth. Major trends in the forecast period include technological advancements, high demand in developed countries, expanding applications in healthcare, the impact of COVID-19, and the use of multiplexing in point-of-care diagnostics.

The point-of-care (POC) coagulation testing market is expected to grow due to the increasing incidence of cardiovascular diseases (CVDs). CVDs encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease and cerebrovascular disease. POC coagulation testing plays a crucial role in CVD treatment by providing real-time information on coagulation status, enabling timely interventions and reducing the risk of bleeding complications, particularly after cardiac surgery. For example, in May 2023, the Centers for Disease Control and Prevention reported that heart disease claimed about 695,000 lives in the United States in 2021, accounting for 1 in 5 deaths. Coronary heart disease, the most common type, caused 375,476 deaths in 2021. This increasing prevalence of cardiovascular diseases is a key driver behind the growth of the POC coagulation testing market.

Major companies in the point-of-care (POC) coagulation testing market are concentrating on strategic collaborations to enhance their competitive position. These collaborations involve formal agreements between two or more parties to work towards specific, mutually beneficial goals. For example, in October 2021, Trivitron Healthcare partnered with Diagon Ltd. and Vanguard Diagnostics to introduce Coagulation Analyzer products. These analyzers offer precise and efficient coagulation testing, with the collaboration aimed at enhancing patient diagnosis and management. The range of analyzers is designed to cater to various healthcare settings, making coagulation testing more accessible.

In December 2023, Roche, a Switzerland-based pharmaceutical company, acquired LumiraDx Ltd. for $350 million. This acquisition enhances Roche's diagnostics portfolio, enabling more patient-centric healthcare through point-of-care solutions that cover the entire patient journey. LumiraDx Ltd., based in the UK, specializes in point-of-care coagulation testing.

Major companies operating in the point-of-care (poc) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

North America was the largest region in the point-of-care (POC) coagulation testing market in 2023. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care (poc) coagulation testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care (POC) coagulation testing market consists of revenues earned by entities by providing coagulation testing services, on-site hemostasis testing, point-of-care diagnostic services, and rapid coagulation analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care (POC) coagulation testing market also includes sales of coagulation analyzers, test strips, prothrombin time (PT) monitors, D-dimer testing devices, and point-of-care coagulation testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care (POC) Coagulation Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care (POC) coagulation testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care (POC) coagulation testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point-of-care (POC) coagulation testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technology: Optical Technology; Mechanical Technology; Electrochemical Technology
  • 2) By Distribution Channel: Direct Tenders; Retail
  • 3) By End-User: Hospitals; Clinics; Home care
  • Companies Mentioned: AT&T Corporation; Siemens Healthcare GmbH; Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-of-Care (POC) Coagulation Testing Market Characteristics

3. Point-of-Care (POC) Coagulation Testing Market Trends And Strategies

4. Point-of-Care (POC) Coagulation Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Point-of-Care (POC) Coagulation Testing Market Size and Growth

  • 5.1. Global Point-of-Care (POC) Coagulation Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Point-of-Care (POC) Coagulation Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Point-of-Care (POC) Coagulation Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Point-of-Care (POC) Coagulation Testing Market Segmentation

  • 6.1. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology
  • 6.2. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Direct Tenders
  • Retail
  • 6.3. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Home care

7. Point-of-Care (POC) Coagulation Testing Market Regional And Country Analysis

  • 7.1. Global Point-of-Care (POC) Coagulation Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Point-of-Care (POC) Coagulation Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market

  • 8.1. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Point-of-Care (POC) Coagulation Testing Market

  • 9.1. China Point-of-Care (POC) Coagulation Testing Market Overview
  • 9.2. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Point-of-Care (POC) Coagulation Testing Market

  • 10.1. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Point-of-Care (POC) Coagulation Testing Market

  • 11.1. Japan Point-of-Care (POC) Coagulation Testing Market Overview
  • 11.2. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Point-of-Care (POC) Coagulation Testing Market

  • 12.1. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Point-of-Care (POC) Coagulation Testing Market

  • 13.1. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Point-of-Care (POC) Coagulation Testing Market

  • 14.1. South Korea Point-of-Care (POC) Coagulation Testing Market Overview
  • 14.2. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Point-of-Care (POC) Coagulation Testing Market

  • 15.1. Western Europe Point-of-Care (POC) Coagulation Testing Market Overview
  • 15.2. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Point-of-Care (POC) Coagulation Testing Market

  • 16.1. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Point-of-Care (POC) Coagulation Testing Market

  • 17.1. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Point-of-Care (POC) Coagulation Testing Market

  • 18.1. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Point-of-Care (POC) Coagulation Testing Market

  • 19.1. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Point-of-Care (POC) Coagulation Testing Market

  • 20.1. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Point-of-Care (POC) Coagulation Testing Market

  • 21.1. Eastern Europe Point-of-Care (POC) Coagulation Testing Market Overview
  • 21.2. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Point-of-Care (POC) Coagulation Testing Market

  • 22.1. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Point-of-Care (POC) Coagulation Testing Market

  • 23.1. North America Point-of-Care (POC) Coagulation Testing Market Overview
  • 23.2. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Point-of-Care (POC) Coagulation Testing Market

  • 24.1. USA Point-of-Care (POC) Coagulation Testing Market Overview
  • 24.2. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Point-of-Care (POC) Coagulation Testing Market

  • 25.1. Canada Point-of-Care (POC) Coagulation Testing Market Overview
  • 25.2. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Point-of-Care (POC) Coagulation Testing Market

  • 26.1. South America Point-of-Care (POC) Coagulation Testing Market Overview
  • 26.2. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Point-of-Care (POC) Coagulation Testing Market

  • 27.1. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Point-of-Care (POC) Coagulation Testing Market

  • 28.1. Middle East Point-of-Care (POC) Coagulation Testing Market Overview
  • 28.2. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Point-of-Care (POC) Coagulation Testing Market

  • 29.1. Africa Point-of-Care (POC) Coagulation Testing Market Overview
  • 29.2. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape And Company Profiles

  • 30.1. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape
  • 30.2. Point-of-Care (POC) Coagulation Testing Market Company Profiles
    • 30.2.1. AT&T Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Siemens Healthcare GmbH
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. F. Hoffmann-La Roche Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Point-of-Care (POC) Coagulation Testing Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Medtronic Plc
  • 31.3. Koninklijke Philips N.V.
  • 31.4. Sysmex Corporation
  • 31.5. IDEXX Laboratories Inc.
  • 31.6. Quidel Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Teleflex Incorporated
  • 31.9. Werfen SA
  • 31.10. Nihon Kohden Corporation
  • 31.11. Horiba Ltd.
  • 31.12. Hycel
  • 31.13. Nova Biomedical Corporation
  • 31.14. Haemonetics Corporation
  • 31.15. Maccura Biotechnology Co. Ltd.

32. Global Point-of-Care (POC) Coagulation Testing Market Competitive Benchmarking

33. Global Point-of-Care (POC) Coagulation Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Point-of-Care (POC) Coagulation Testing Market

35. Point-of-Care (POC) Coagulation Testing Market Future Outlook and Potential Analysis

  • 35.1 Point-of-Care (POC) Coagulation Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Point-of-Care (POC) Coagulation Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Point-of-Care (POC) Coagulation Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer